Argenx
ARGX
#555
Rank
S$49.36 B
Marketcap
$784.53
Share price
2.91%
Change (1 day)
46.19%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: S$49.36 Billion

As of April 2025 Argenx has a market cap of S$49.36 Billion. This makes Argenx the world's 555th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025S$49.36 B-3.02%
2024S$50.90 B70.8%
2023S$29.80 B6.08%
2022S$28.09 B13.01%
2021S$24.86 B34.03%
2020S$18.55 B100.04%
2019S$9.27 B93.6%
2018S$4.78 B78.62%
2017S$2.68 B
2014S$0.19 B

End of Day market cap according to different sources

On Apr 2nd, 2025 the market cap of Argenx was reported to be:

S$47.84 Billion
by Nasdaq info icon info icon
S$49.36 Billion
by CompaniesMarketCap info icon info icon
S$49.36 Billion
by Yahoo Finance info icon info icon